title: A multi-state model approach for prediction in chronic myeloid leukaemia.
abstract: Multi-state models support prediction in medicine. With different states of disease, chronic myeloid leukaemia (CML) is particularly suited for the application of multi-state models. In this article, we tried to find a model for CML that allows predicting the prevalence of three different states (initial state of disease, remission and progression) in dependence on treatment, adjusted for age, sex and risk score. Based on the German CML Study IV, one of the largest randomised studies in CML, the model was able to represent the known effects of age and risk score on the probabilities of remission and progression. Patients achieving a major molecular remission had a better chance of surviving without progression, but this effect was not significant. Comparing treatments, patient of the high-dose arm had the greatest chance to be in the state "remission" at 5 years but did not seem to have an advantage considering "progression". The proposed illness-death model can be useful for predicting the course of CML based on the patient's individual covariates (trial registration: this is an explorative analysis of ClinicalTrials.gov Identifier: NCT00055874).
authors.affiliation: Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377, München, Germany, lauseker@ibe.med.uni-muenchen.de.
authors.forename: Michael
authors.initials: M
authors.lastname: Lauseker
authors.forename: Joerg
authors.initials: J
authors.lastname: Hasford
authors.forename: Verena S
authors.initials: VS
authors.lastname: Hoffmann
authors.forename: Martin C
authors.initials: MC
authors.lastname: Müller
authors.forename: Rüdiger
authors.initials: R
authors.lastname: Hehlmann
authors.forename: Markus
authors.initials: M
authors.lastname: Pfirrmann
mesh_terms: D000328:Adult; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000453:epidemiology*; D008297:Male; D008390:Markov Chains; D008875:Middle Aged; D008962:Models, Theoretical; D016896:Treatment Outcome